Posted on

Additionally, our patient did not present clinical or biological evidence of bacterial surinfection or other opportunistic infection after the introduction of tocilizumab

Additionally, our patient did not present clinical or biological evidence of bacterial surinfection or other opportunistic infection after the introduction…

Additionally, our patient did not present clinical or biological evidence of bacterial surinfection or other opportunistic infection after the introduction of tocilizumab Read More